首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備 DDS

2030 年亞太地區經皮給藥系統市場預測 - 區域分析 - 按類型、應用和配銷通路

市場調查報告書

商品編碼

1510743

2030 年亞太地區經皮給藥系統市場預測 - 區域分析 - 按類型、應用和配銷通路

Asia Pacific Transdermal Drug Delivery System Market Forecast to 2030 - Regional Analysis - by Type, Application, and Distribution Channel

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 112 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

亞太地區經皮給藥系統市場預計將從2022年的90.2989億美元成長到2030年的128.2077億美元。

智慧貼片和 3D 列印貼片的進步推動亞太地區經皮給藥系統市場

經皮給藥途徑是新穎的，也是持續給藥的可靠方法之一。隨著這一領域的大量研究的開展以及研究人員對這種藥物輸送形式的興趣日益濃厚，未來可能會有大量經皮貼片進入市場。經皮貼片用於輸送尼古丁、芬太尼、硝酸甘油和可樂定等藥物來治療各種疾病。最近，這些貼片已被探索在各種應用中提供生物製劑。智慧貼片配備了感測器和其他技術來監測患者狀況並相應調整藥物傳遞。 2023 年 1 月，斯旺西大學的一位首席科學家開發了一種新型智慧貼片，利用微針技術檢測帕金森氏症和阿茲海默症等神經退化性疾病的促炎生物標記。這些智慧貼片包含大量微針，旨在以微創方式穿經皮膚屏障，然後監測具有臨床意義的生物標記。它們可以在全科診所或家中自我管理以進行即時診斷。這項創新研究可能會改變早期神經退化性疾病檢測的格局。

根據2021年11月發表在美國國家醫學圖書館的一篇題為《局部皮膚應用的3D列印產品：從個人化敷料到藥物輸送》的文章稱，貼合皮膚表面的個人化3D列印貼片可用於乙醯化-六肽3 (AHP-3) 遞送。在這項研究中，兩種液體單體——聚乙二醇二丙烯酸酯（PEGDA）和乙烯基吡咯烷酮（VP）——以不同的比例使用，以提高最終聚合物的機械強度、聚合速率和溶脹速率。樹脂上的最佳載藥量表明 AHP-3 在整個製造過程中保持穩定，並且對最終聚合物的物理性能沒有影響。使用 3D 掃描臉部模型，在電腦輔助設計軟體中設計個人化貼片，並使用數位光處理 3D 列印機以最佳化樹脂製造。製備的經皮貼片的體外表徵表明它們能夠穿透人體屍體皮膚，並在壓縮後進一步保持完整。「用於局部皮膚應用的3D 列印產品：從個人化敷料到藥物輸送」是第一個展示使用光聚合物製成的個人化貼片的研究，它引入了一種改進藥物經皮輸送的新方法，以實現有效的皺紋管理。

因此，3D列印技術和智慧貼片的採用可能會在未來幾年為經皮給藥系統市場提供機會。

亞太地區經皮給藥系統市場概況

亞太地區經皮給藥系統市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。由於人口老化加劇、心血管疾病盛行率增加以及對非侵入性醫療設備的需求不斷增加，預計中國、印度和澳洲等國家的市場將成長最快。在亞太地區，中國是最大的經皮給藥系統市場。中國經皮給藥系統市場的成長主要歸因於該國技術的不斷發展，市場參與者不斷開發用於疼痛管理的經皮貼片和半固體產品。

此外，在過去幾年中，中國的公司正在進行產品上市和批准、收購、合作和合併，以擴大其在經皮給藥系統產業的業務。例如，2022年1月，蘇州瑞維達醫療器材有限公司（REVEDA）宣布與翰宇藥業股份有限公司（簡稱「翰宇藥業」）合作成立藥械組合產品合資公司，並在藥械組合產品領域展開合作。 REVEDA Medical將持有合資公司60%的股份，Hybio Pharmaceutical將持有40%的股份。此外，2021年9月，英國藥品和保健品監管局批准綠葉製藥集團創新製劑卡巴拉汀多日經皮貼片（卡巴拉汀MD）上市，用於治療與阿茲海默症相關的輕至中度癡呆。一些歐盟國家已經獲得了該藥物的上市許可。因此，由於上述因素，預計未來幾年市場將推動該國對經皮給藥系統的需求。

亞太地區經皮給藥系統市場收入及 2030 年預測（百萬美元）

亞太地區經皮給藥系統市場區隔

亞太地區經皮給藥系統市場按類型、應用、配銷通路和國家細分。

根據類型，亞太地區經皮給藥系統市場分為經皮貼片、經皮凝膠、經皮噴霧等。到2022年，經皮凝膠細分市場將佔據亞太地區經皮給藥系統市場的最大佔有率。貼劑。

從應用來看，亞太地區經皮給藥系統市場分為心血管疾病、中樞神經系統疾病、疼痛管理、荷爾蒙應用和其他應用。到2022年，疼痛管理細分市場將佔據亞太地區經皮給藥系統市場的最大佔有率。荷爾蒙應用進一步細分為經皮雌激素和黃體素治療以及睪固酮替代療法。

依配銷通路，亞太地區經皮給藥系統市場分為醫院藥局、零售藥局、網路藥局等。 2022年，醫院藥局部門在亞太地區經皮給藥系統市場中佔有最大佔有率。

依國家/地區分類，亞太地區經皮給藥系統市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年，中國將主導亞太地區經皮給藥系統市場。

勃林格殷格翰國際有限公司、葛蘭素史克公司、久光製藥有限公司、強生公司、綠葉製藥Group Limited、諾華公司和 Viatris Inc 是亞太地區經皮給藥系統市場的一些領先公司。

A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson's and Alzheimer's using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.

According to an article titled "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery," published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery" is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.

Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.

Asia Pacific Transdermal Drug Delivery System Market Overview

The Asia Pacific transdermal drug delivery systems market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth is expected to be fastest in countries such as China, India, and Australia due to growing aging population, increasing prevalence of cardiovascular diseases, and increasing demand for non-invasive medical devices. In Asia Pacific, China is the largest market of transdermal drug delivery systems. The growth of the transdermal drug delivery system market in China is primarily attributed to the growing technology in the country, increasing developments by the market players to develop transdermal patches and semisolid products for pain management.

Also, in the last few years, companies in China are undergoing product launches and approvals, acquisitions, partnerships, and mergers to expand their business in the transdermal drug delivery systems industry. For instance, in January 2022, Suzhou Reveda Medical Co., Ltd. (REVEDA) announced that it partnered with Hybio Pharmaceutical Co., Ltd. (Hybio Pharmaceutical) to set up a joint venture for drug-device combination products and team up in the field of polypeptide micro-needles for transdermal delivery. 60% of the joint venture will be owned by REVEDA Medical and 40% by Hybio Pharmaceutical. Furthermore, in September 2021, the UK's Medicines and Healthcare Products Regulatory Agency granted marketing approval for Luye Pharma Group's innovative formulation Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD) for the treatment of mild to moderate dementia associated with Alzheimer's disease. Several European Union nations already have marketing authorization for the medicine. Thus, owing to the abovementioned factors, the market is expected to propel the demand for transdermal drug delivery systems in this country in the upcoming years.

Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Transdermal Drug Delivery System Market Segmentation

The Asia Pacific transdermal drug delivery system market is segmented into type, application, distribution channel, and country.

Based on type, the Asia Pacific transdermal drug delivery system market is segmented into transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal gel segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The transdermal patches is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and vapor patches.

In terms of application, the Asia Pacific transdermal drug delivery system market is categorized into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The pain management segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The pain management is further sub segmented into opioid and non-opioid. The hormonal applications is further sub segmented into transdermal estrogen & progesterone therapy and testosterone replacement.

By distribution channel, the Asia Pacific transdermal drug delivery system market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The hospitals pharmacies segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022.

Based on country, the Asia Pacific transdermal drug delivery system market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific transdermal drug delivery system market in 2022.

Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Luye Pharma Group Ltd, Novartis AG, and Viatris Inc are some of the leading companies operating in the Asia Pacific transdermal drug delivery system market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Transdermal Drug Delivery System Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Chronic Diseases
- 4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
- 4.1.3 High Demand for Self-Administration of Drugs
4.2 Market Restraints
- 4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
4.3 Market Opportunities
- 4.3.1 Advancements in Smart Patches and 3D-Printed Patches
4.4 Future Trends
- 4.4.1 Strategic Initiatives by Manufacturers
4.5 Impact Analysis

5. Transdermal Drug Delivery System Market - Asia Pacific Market Analysis

5.1 Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type

6.1 Overview
6.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Transdermal Patches
- 6.3.1 Overview
- 6.3.2 Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.1 Drug-in-Adhesive Patches
    - 6.3.2.1.1 Overview
    - 6.3.2.1.2 Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.2 Matrix Patches
    - 6.3.2.2.1 Overview
    - 6.3.2.2.2 Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.3 Reservoir Membrane Patches
    - 6.3.2.3.1 Overview
    - 6.3.2.3.2 Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.4 Vapor Patches
    - 6.3.2.4.1 Overview
    - 6.3.2.4.2 Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Transdermal Gels
- 6.4.1 Overview
- 6.4.2 Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Transdermal Sprays
- 6.5.1 Overview
- 6.5.2 Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cardiovascular Diseases
- 7.3.1 Overview
- 7.3.2 Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Central Nervous System Disorders
- 7.4.1 Overview
- 7.4.2 Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Pain Management
- 7.5.1 Overview
- 7.5.2 Pain Management: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.5.2.1 Opioid
    - 7.5.2.1.1 Overview
    - 7.5.2.1.2 Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.5.2.2 Non-Opioid
    - 7.5.2.2.1 Overview
    - 7.5.2.2.2 Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hormonal Applications
- 7.6.1 Overview
- 7.6.2 Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.6.2.1 Transdermal Estrogen & Progesterone Therapy
    - 7.6.2.1.1 Overview
    - 7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.6.2.2 Testosterone Replacement
    - 7.6.2.2.1 Overview
    - 7.6.2.2.2 Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Other Application
- 7.7.1 Overview
- 7.7.2 Other Application: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview
8.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacies
- 8.3.1 Overview
- 8.3.2 Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacies
- 8.4.1 Overview
- 8.4.2 Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
- 8.5.1 Overview
- 8.5.2 Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Asia Pacific Transdermal Drug Delivery System Market
- 9.1.1 Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  - 9.1.1.1 China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.1.1 Overview
    - 9.1.1.1.2 China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.1.3 China: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.1.3.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.1.4 China: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.1.4.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.1.4.2 China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.1.5 China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 9.1.1.2 Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.2.1 Overview
    - 9.1.1.2.2 Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.2.3 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.2.3.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.2.4 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.2.4.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.2.4.2 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.2.5 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 9.1.1.3 India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.3.1 Overview
    - 9.1.1.3.2 India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.3.3 India: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.3.3.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.3.4 India: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.3.4.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.3.4.2 India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.3.5 India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 9.1.1.4 Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.4.1 Overview
    - 9.1.1.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.4.3 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.4.3.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.4.4 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.4.4.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.4.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.4.5 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 9.1.1.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.5.1 Overview
    - 9.1.1.5.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.5.3 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.5.3.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.5.4 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.5.4.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.5.4.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.5.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 9.1.1.6 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.6.1 Overview
    - 9.1.1.6.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.6.3 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.6.3.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.6.4 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.6.5 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Transdermal Drug Delivery System Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Transdermal Drug Delivery System Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Novartis AG
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Johnson & Johnson
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 GSK Plc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Viatris Inc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Boehringer Ingelheim International GmbH
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Hisamitsu Pharmaceutical Co Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Luye Pharma Group Ltd
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Transdermal Drug Delivery System Market Segmentation
Table 2. China: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 12. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 14. India: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 15. India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 16. India: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 18. India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 19. India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 23. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 24. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 28. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 29. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 31. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 37. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 38. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
Table 39. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
Table 40. Glossary of Terms, Asia Pacific Transdermal Drug Delivery System Market

List Of Figures

Figure 1. Asia Pacific Transdermal Drug Delivery System Market Segmentation, By Country
Figure 2. Asia Pacific Transdermal Drug Delivery System Market: Key Industry Dynamics
Figure 3. Asia Pacific Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Pain Management: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Other Application: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 25. Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Asia Pacific Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 31. China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 36. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 37. Growth Strategies in the Transdermal Drug Delivery System Market